Alzheimer's and Dementia

Kevin Church, Chief Science Officer of Athira Pharma, joins Suzanne to talk about what happens to the brain when someone has Alzheimer's, and how Athira's clinical trial aims to reverse damage done to brain cells by Alzheimer's.

Kevin Church, Chief Science Officer of Athira Pharma, provides an overview of what happens in a trial, how long they last, and the different kinds of clinical trials.

Kevin Church, Chief Science Officer of Athira Pharma, provides an overview of clinical trials, how to find clinical trial locations, and what sorts of things the doctors are looking for in a participant.

Dr. Michael Mega, director of the Center for Cognitive Health in Portland, OR, talks about how diet, lifestyle, cognitive stimulation, and genetics all play into the paths to influence whether we can avoid Alzheimer's.

Dr. Michael Mega, director of the Center for Cognitive Health in Portland, OR, talks about being able to detect biomarkers for the tau and amyloid plaques that are believed to cause Alzheimer's.

Dr. Michael Mega, director of the Center for Cognitive Health in Portland, OR, talks about the best way to get treatments right now for Alzheimer's is to take part in a clinical trial.

David Troxel joins Suzanne to talk about his book The Best Friend's Approach to Dementia Care, courtesy of Era Living.

Courtesy of Athira Pharma, Psychiatrist and Medical Director Bernardo Ng of the Sun Valley Research Center joins Suzanne to talk about Alzheimer's clinical trials, particularly in underserved groups such at the Latino populations in the United States.

Psychiatrist and Medical Director Bernardo Ng of the Sun Valley Research Center joins Suzanne to talk about specific challenges for the Latino community in signing up for Alzheimer's clinical trials, courtesy of Athira Pharma.

Dementia family coach Faith Marshall joins Suzanne to talk about senior scams, how and where they show up.